Carl Zeiss AG
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Carl Zeiss AG - overview
Location
-, -, Germany
Primary Industry
Healthcare Specialists
About
Carl Zeiss AG specializes in the development and manufacturing of advanced optical and optoelectronic products, providing innovative solutions across various sectors, including healthcare, industrial applications, and scientific research. Founded in 1846 by Carl Zeiss in Jena, Germany, Carl Zeiss AG operates as a leading manufacturer of optical systems and equipment. The company has maintained a focus on precision optics and has expanded its operations to multiple global locations, with headquarters located in Oberkochen, Germany. Over the years, Zeiss has adapted its business strategy to incorporate digital solutions and expand its services to various industries, including healthcare and manufacturing.
Zeiss is a global leader recognized for its advanced optical and optoelectronic products and solutions, which cater to various industries, including vision care, medical technology, semiconductor manufacturing, and industrial quality assurance. Its core offerings encompass a wide range of products such as ophthalmic lenses, surgical microscopes, semiconductor manufacturing equipment, and precision measurement tools. Zeiss's products are designed to enhance vision and medical outcomes, improve manufacturing processes, and facilitate research in microscopy and material sciences. The company serves diverse customer segments, including eye care professionals, semiconductor manufacturers, industrial clients, and photography enthusiasts.
Zeiss operates across multiple geographical markets, including North America, Europe, and Asia, ensuring a broad reach to its varied customer base. In the fiscal year 2023, Carl Zeiss AG reported a revenue of USD 10. 80 bn and an EBITDA of USD 2. 26 bn.
The company generates revenue through a combination of direct sales and partnerships across its multiple product lines. Transactions typically occur through B2B relationships, where industrial and medical clients purchase high-value equipment like surgical microscopes and semiconductor manufacturing systems, as well as through retail channels for consumer products such as eyeglass lenses and photography equipment. The company maintains a pricing structure that reflects the quality and technological advancements of its flagship products, such as the Zeiss surgical microscope and industrial measurement systems. Revenue is bolstered by ongoing service contracts and software solutions that accompany their hardware products, providing customers with holistic solutions that integrate seamlessly into their operations.
The diverse portfolio allows Zeiss to attract various clients, from healthcare institutions to manufacturing firms, solidifying its position as a leader in optical technology. Carl Zeiss AG plans to continue its expansion strategy by developing new product lines in the areas of digital imaging and augmented reality. The company anticipates launching several innovative products in the next 18 months that focus on improving user experience and functionality. Additionally, Zeiss aims to penetrate new markets in Southeast Asia and South America by 2025, targeting increased partnerships with local distributors.
The recent funding, amounting to USD 10. 80 bn, will be utilized to support these product development initiatives and market expansions, enhancing the company’s capacity to innovate and serve a broader customer base.
Primary Industry
Healthcare Specialists
Sub Industries
Optometrists & Opticians Products and Services
Website
www.zeiss.com
Total Amount Raised
Subscriber access only
Carl Zeiss AG - timeline of key events
Carl Zeiss AG - financials
| Fiscal Year Ended | Sep 30, 2011 | Sep 30, 2012 | Sep 30, 2013 | Sep 30, 2014 | Sep 30, 2015 | Sep 30, 2016 | Sep 30, 2017 | Sep 30, 2018 | Sep 30, 2019 | Sep 30, 2020 | Sep 30, 2021 | Sep 30, 2022 | Sep 30, 2023 | Sep 30, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 758,793,000 | 861,875,000 | 906,445,000 | 909,255,000 | 4,510,862,000 | 4,880,839,000 | 5,347,804,000 | 5,817,170,000 | 6,428,055,000 | 6,296,542,000 | 7,528,928,000 | - | - | - |
| % Revenue Growth (YoY) | - | 13.6% | 5.2% | 0.3% | 396.1% | 8.2% | 9.6% | 8.8% | 10.5% | (2.0%) | 19.6% | - | - | - |
| EBITDA (USD) | 122,508,000 | 140,795,000 | 152,593,000 | 138,658,000 | 515,195,000 | 806,215,000 | 1,022,611,000 | 986,249,000 | 1,335,277,000 | 1,262,166,000 | 1,795,395,000 | - | - | - |
| Operating Income (USD) | 103,566,000 | 122,900,000 | 133,874,000 | 120,705,000 | 313,139,000 | 603,059,000 | 807,735,000 | 743,905,000 | 1,016,131,000 | 924,285,000 | 1,460,527,000 | - | - | - |
| Operating Margin | 13.6% | 14.3% | 14.8% | 13.3% | 6.9% | 12.4% | 15.1% | 12.8% | 15.8% | 14.7% | 19.4% | - | - | - |
| % EBITDA Margin | 16.1% | 16.3% | 16.8% | 15.2% | 11.4% | 16.5% | 19.1% | 17.0% | 20.8% | 20.0% | 23.8% | - | - | - |
| NET Income (USD) | 72,274,000 | 76,392,000 | 99,122,000 | 79,157,000 | 208,207,000 | 403,844,000 | 561,370,000 | 535,029,000 | 747,535,000 | 615,712,000 | 1,047,097,000 | - | - | - |
| % Net Margin | 9.5% | 8.9% | 10.9% | 8.7% | 4.6% | 8.3% | 10.5% | 9.2% | 11.6% | 9.8% | 13.9% | - | - | - |
Carl Zeiss AG - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Carl Zeiss Vision | - | ||||||||
| Trade Sale | Completed | P.A.L.M. Microlaser Technologies GmbH | - |
Displaying 1 - 2 of 2
Carl Zeiss AG - employee data
Carl Zeiss AG - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Member of the Executive Board of the ZEISS Group | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.